Contact UsInvestorsCareersMediaScienceContact Us
HomePartnershipsWorking with the NHS and other Healthcare OrganisationsDonations and GrantsDonations of Goods, Services and Benefit in KindOncology Donation: Breast Clinical Audit ToolkitOncology Donation: Breast Clinical Audit ToolkitSupporting healthcare professionals in clinical auditing of their breast cancer practice to improve patient outcomes.

Pfizer UK will provide subscription access to the Ledidi Core platform, a cloud-based service, which is an all-in-one platform for collecting, structuring, analysing and visualising data in a GDPR compliant platform with a built in mechanism of collaboration.  The platform allows for the creation of registries, research projects and multi-centre collaborations with real time statistical analytics.  The sharing of data between collaborators is controlled by the lead Trust and the platform does not limit the number of projects/registries/collaborations.

Below is a selection of institutions currently using the Ledidi Core platform to run local, national, and international registries:

The Pfizer donation will consist of two options:

Option 1 (Donation and Grant)

Option 2 (Donation only)

Neither Pfizer nor Ledidi will have access to or be privy to any data entered onto the site, the trust remains the data owners and all anonymised patient information remains the property of the trust.  Any sharing of data by the trust is through their own collaborations either within or outside of the platform and Ledidi is required to maintain adherence to data privacy laws.

All NHS hospitals within the UK treating breast cancer are permitted to apply for this service donation grant. Eighty subscriptions in total are available and NHS trusts will be selected to receive this donation on a first-come, first-served basis and based on the below criteria:

For further information on the data privacy and security of the Ledidi Core platform please refer to the following links. 

Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd.  Pfizer accepts no responsibility for the content or services of the linked site.

All applications will be reviewed in order of application date and time on a first-come, first-served basis. Once all subscriptions have been allocated then the application portal will close. If a large number of applications are received all at once then the application portal may close until the backlog of applications is reviewed or until all grants are allocated, whichever occurs first.

All applications will be reviewed by an internal Pfizer medical review panel. Once you have submitted a request, we will also share further information regarding Ledidi Core.  Additional clarification during the review period may be requested. All applicants will be notified via email regarding the outcome of their request, upon completion of the internal review process.

If your application is approved, your institution will be required to enter into a written grant agreement with Pfizer. In the event of a successful application, core terms of the agreement will be provided at a later date. Disclosure of this Pfizer donation (with/without a grant) will be required by each recipient hospital.

Apply for the Breast Clinical Audit Toolkit Donation
PP-UNP-GBR-8487 / March 2024
Science Products Responsibility PartnershipsCareers Privacy Statement Terms of Use Contact UsSitemap Copyright © 2017-2024 Pfizer Limited. PP-UNP-GBR-8108 / January 2024. All rights reserved. Registered in England and Wales No. 526209. Registered office: Ramsgate Road, Sandwich, Kent CT13 9NJ. VAT No. GB201048427. This website is intended for the general public in the UK.